Operating Margin in % of Karyopharm Therapeutics Inc. from 2016 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Karyopharm Therapeutics Inc. quarterly/annual Operating Margin history and growth rate from 2016 to Q3 2025.
  • Karyopharm Therapeutics Inc. Operating Margin for the quarter ending September 30, 2025 was -73.1 %, a 13.9% increase year-over-year.
  • Karyopharm Therapeutics Inc. annual Operating Margin for 2024 was -82.2 %, a 7.29% increase from 2023.
  • Karyopharm Therapeutics Inc. annual Operating Margin for 2023 was -88.7 %, a 2.02% increase from 2022.
  • Karyopharm Therapeutics Inc. annual Operating Margin for 2022 was -90.5 %, a 93.3% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)

Karyopharm Therapeutics Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -73.1 +11.8 +13.9% Jul 1, 2025 Sep 30, 2025
Q2 2025 -83.9 +5.97 +6.64% Apr 1, 2025 Jun 30, 2025
Q1 2025 -83.7 +10.6 +11.2% Jan 1, 2025 Mar 31, 2025
Q4 2024 -82.2 +6.47 +7.29% Oct 1, 2024 Dec 31, 2024
Q3 2024 -84.9 +1.25 +1.45% Jul 1, 2024 Sep 30, 2024
Q2 2024 -89.9 -4.16 -4.85% Apr 1, 2024 Jun 30, 2024
Q1 2024 -94.3 -0.73 -0.78% Jan 1, 2024 Mar 31, 2024
Q4 2023 -88.7 +1.83 +2.02% Oct 1, 2023 Dec 31, 2023
Q3 2023 -86.1 -61.5 -250% Jul 1, 2023 Sep 30, 2023
Q2 2023 -85.7 -56.2 -190% Apr 1, 2023 Jun 30, 2023
Q1 2023 -93.5 -59.2 -172% Jan 1, 2023 Mar 31, 2023
Q4 2022 -90.5 -43.7 -93.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -24.6 +129 +84% Jul 1, 2022 Sep 30, 2022
Q2 2022 -29.6 +152 +83.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -34.4 +122 +78% Jan 1, 2022 Mar 31, 2022
Q4 2021 -46.8 +112 +70.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 -154 +41.8 +21.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -181 +24.1 +11.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -156 +135 +46.4% Jan 1, 2021 Mar 31, 2021
Q4 2020 -159 +304 +65.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -195 +689 +77.9% Jul 1, 2020 Sep 30, 2020
Q2 2020 -205 +1.91K +90.3% Apr 1, 2020 Jun 30, 2020
Q1 2020 -292 +713 +71% Jan 1, 2020 Mar 31, 2020
Q4 2019 -463 +130 +21.9% Oct 1, 2019 Dec 31, 2019
Q3 2019 -885 Jul 1, 2019 Sep 30, 2019
Q2 2019 -2.11K Apr 1, 2019 Jun 30, 2019
Q1 2019 -1K Jan 1, 2019 Mar 31, 2019
Q4 2018 -593 Oct 1, 2018 Dec 31, 2018

Karyopharm Therapeutics Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -82.2 +6.47 +7.29% Jan 1, 2024 Dec 31, 2024
2023 -88.7 +1.83 +2.02% Jan 1, 2023 Dec 31, 2023
2022 -90.5 -43.7 -93.3% Jan 1, 2022 Dec 31, 2022
2021 -46.8 +112 +70.5% Jan 1, 2021 Dec 31, 2021
2020 -159 +304 +65.6% Jan 1, 2020 Dec 31, 2020
2019 -463 +130 +21.9% Jan 1, 2019 Dec 31, 2019
2018 -593 +7.54K +92.7% Jan 1, 2018 Dec 31, 2018
2017 -8.13K +63.8K +88.7% Jan 1, 2017 Dec 31, 2017
2016 -71.9K Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.